The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.

INBX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.20%

Insider Buying (Last 12 Months): $9,899,982.45

Insider Selling (Last 12 Months): $0.00

Inhibrx Insider Trading History Chart

Inhibrx Share Price & Price History

^$34.45

▼ -0.16 (-0.46%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Inhibrx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2023	Global Investors Lp Viking	Major Shareholder	Buy	511,627	$19.35	$9,899,982.45	511,627
2/1/2023	Brendan P. Eckelman	Insider	Sell	28,750	$24.73	$710,987.50	2,086,803
1/23/2023	Jon Faiz Kayyem	Director	Sell	9,500	$25.26	$239,970.00	3,224,301
1/23/2023	Mark Lappe	CEO	Sell	21,665	$25.36	$549,424.40	2,490,587
1/3/2023	Brendan P. Eckelman	Insider	Sell	32,895	$23.77	$781,914.15	2,122,658
12/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$27.02	$256,690.00	3,233,801
12/19/2022	Mark Lappe	CEO	Sell	26,000	$25.56	$664,560.00	2,512,252
12/6/2022	Brendan P. Eckelman	Insider	Sell	40,000	$27.22	$1,088,800.00	2,155,553
11/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$29.89	$283,955.00	3,243,301
11/1/2022	Brendan P. Eckelman	Insider	Sell	40,000	$33.51	$1,340,400.00	2,195,553
10/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$30.13	$286,235.00	3,252,801
10/17/2022	Mark Lappe	CEO	Sell	26,000	$29.59	$769,340.00	2,564,252
10/7/2022	Global Investors Lp Viking	Major Shareholder	Buy	1,333,333	$30.00	$39,999,990.00	2,427,307
10/4/2022	Brendan P. Eckelman	Insider	Sell	40,000	$27.82	$1,112,800.00	2,235,553
8/2/2022	Brendan P. Eckelman	Insider	Sell	24,500	$17.70	$433,650.00	2,491,053
7/7/2022	Brendan P. Eckelman	Insider	Sell	40,000	$17.17	$686,800.00	2,515,553
4/5/2022	Brendan P. Eckelman	Insider	Sell	400	$25.04	$10,016.00

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

SEC Filings (Institutional Ownership Changes) for Inhibrx (NASDAQ:INBX)

82.46% of Inhibrx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Inhibrx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2024	Hennion & Walsh Asset Management Inc.	30,561	$1.07M	0.1%	+2.5%	0.064%
3/11/2024	Vanguard Group Inc.	1,874,323	$71.22M	0.0%	+4.7%	3.955%
3/5/2024	Wellington Management Group LLP	145,398	$5.53M	0.0%	-16.9%	0.307%
2/20/2024	Readystate Asset Management LP	13,839	$0.53M	0.0%	N/A	0.029%
2/20/2024	Quarry LP	750	$28K	0.0%	N/A	0.002%
2/16/2024	Price T Rowe Associates Inc. MD	13,700	$0.52M	0.0%	+7.8%	0.029%
2/15/2024	Exome Asset Management LLC	73,158	$2.78M	2.7%	N/A	0.155%
2/15/2024	Virtus ETF Advisers LLC	3,362	$0.13M	0.1%	-8.6%	0.007%
2/15/2024	Legal & General Group Plc	19,265	$0.73M	0.0%	-13.1%	0.041%
2/15/2024	Barclays PLC	88,865	$3.11M	0.0%	+40.7%	0.188%
2/15/2024	Sphera Funds Management LTD.	226,551	$8.61M	1.4%	-11.6%	0.479%
2/15/2024	Vanguard Group Inc.	1,874,323	$71.22M	0.0%	+4.7%	3.963%
2/15/2024	West Tower Group LLC	2,300	$87K	0.2%	N/A	0.005%
2/15/2024	Nuveen Asset Management LLC	84,011	$3.19M	0.0%	-5.9%	0.178%
2/15/2024	PFM Health Sciences LP	537,964	$20.44M	1.2%	+86.4%	1.138%
2/15/2024	Prelude Capital Management LLC	16,236	$0.62M	0.0%	+22.8%	0.034%
2/15/2024	Price T Rowe Associates Inc. MD	13,700	$0.52M	0.0%	+7.8%	0.029%
2/15/2024	Profund Advisors LLC	17,124	$0.65M	0.0%	-13.3%	0.036%
2/15/2024	Birchview Capital LP	48,448	$1.84M	1.5%	-31.2%	0.102%
2/14/2024	Royal Bank of Canada	15,993	$0.61M	0.0%	+208.7%	0.034%
2/14/2024	Creative Planning	13,270	$0.50M	0.0%	+8.9%	0.028%
2/14/2024	Bellevue Group AG	24,600	$0.94M	0.0%	-49.6%	0.052%
2/14/2024	Platinum Investment Management Ltd.	167,763	$6.38M	0.3%	-26.8%	0.355%
2/14/2024	Vestal Point Capital LP	1,530,000	$58.14M	6.2%	N/A	3.235%
2/14/2024	Schroder Investment Management Group	131,295	$4.99M	0.0%	-44.7%	0.278%
2/13/2024	Northern Trust Corp	313,889	$11.93M	0.0%	-0.5%	0.664%
2/13/2024	Tower Research Capital LLC TRC	5,637	$0.21M	0.0%	-4.6%	0.012%
2/13/2024	Capital Research Global Investors	712,360	$27.07M	0.0%	-41.7%	1.506%
2/13/2024	Goldman Sachs Group Inc.	153,180	$5.82M	0.0%	-3.9%	0.324%
2/13/2024	Rafferty Asset Management LLC	103,246	$3.92M	0.0%	-10.9%	0.218%
2/13/2024	The Manufacturers Life Insurance Company	13,387	$0.51M	0.0%	-2.1%	0.028%
2/13/2024	Campbell & CO Investment Adviser LLC	23,516	$0.89M	0.1%	N/A	0.050%
2/13/2024	California State Teachers Retirement System	23,150	$0.88M	0.0%	-24.6%	0.049%
2/9/2024	HCR Wealth Advisors	6,300	$0.24M	0.0%	N/A	0.013%
2/9/2024	UBS Group AG	80,785	$3.07M	0.0%	+112.6%	0.171%
2/8/2024	Quadrant Capital Group LLC	690	$26K	0.0%	N/A	0.001%
2/7/2024	Principal Financial Group Inc.	10,368	$0.39M	0.0%	-3.7%	0.022%
2/7/2024	E Fund Management Co. Ltd.	5,512	$0.21M	0.0%	N/A	0.012%
2/6/2024	Charles Schwab Investment Management Inc.	229,866	$8.74M	0.0%	+8.4%	0.486%
2/6/2024	AJOVista LLC	678	$26K	0.0%	N/A	0.001%
2/6/2024	M&T Bank Corp	23,843	$0.91M	0.0%	-16.4%	0.050%
2/6/2024	Amalgamated Bank	4,250	$0.16M	0.0%	-7.6%	0.009%
2/6/2024	Swiss National Bank	38,700	$1.47M	0.0%	-32.8%	0.082%
2/5/2024	Russell Investments Group Ltd.	435,450	$16.55M	0.0%	-5.1%	0.921%
2/1/2024	Signaturefd LLC	758	$29K	0.0%	+4,637.5%	0.002%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	20,494	$0.78M	0.0%	+6.9%	0.043%
1/24/2024	Arizona State Retirement System	5,494	$0.21M	0.0%	N/A	0.012%
1/24/2024	China Universal Asset Management Co. Ltd.	5,471	$0.21M	0.0%	+389.8%	0.012%
1/5/2024	Exchange Traded Concepts LLC	6,705	$0.26M	0.0%	+34.0%	0.014%
12/18/2023	Vanguard Group Inc.	1,789,811	$32.84M	0.0%	+1.0%	3.785%
12/6/2023	Citigroup Inc.	49,244	$0.90M	0.0%	+3.4%	0.104%
12/1/2023	Wellington Management Group LLP	174,899	$3.21M	0.0%	+24.4%	0.370%
11/24/2023	Deutsche Bank AG	16,224	$0.30M	0.0%	+15.3%	0.034%
11/21/2023	Walleye Capital LLC	70,850	$1.30M	0.0%	+114.0%	0.150%
11/16/2023	Tudor Investment Corp Et Al	21,710	$0.40M	0.0%	N/A	0.046%
11/15/2023	RA Capital Management L.P.	4,724,207	$86.69M	1.7%	+22.6%	9.990%
11/15/2023	Schroder Investment Management Group	237,443	$4.36M	0.0%	-26.1%	0.502%
11/14/2023	Eventide Asset Management LLC	434,026	$7.96M	0.1%	N/A	0.994%
11/14/2023	California State Teachers Retirement System	30,704	$0.56M	0.0%	-10.8%	0.070%
11/14/2023	Tower Research Capital LLC TRC	5,906	$0.11M	0.0%	+142.5%	0.014%
11/14/2023	Profund Advisors LLC	19,746	$0.36M	0.0%	-18.3%	0.045%
11/13/2023	Northern Trust Corp	315,418	$5.79M	0.0%	-4.1%	0.722%
11/13/2023	Invesco Ltd.	19,010	$0.35M	0.0%	-67.9%	0.044%
11/13/2023	FMR LLC	1,517,595	$27.85M	0.0%	-14.3%	3.475%
11/13/2023	Rafferty Asset Management LLC	115,828	$2.13M	0.0%	-12.4%	0.265%
11/9/2023	Loomis Sayles & Co. L P	1,116,484	$20.49M	0.0%	-3.0%	2.557%
11/9/2023	Rhumbline Advisers	48,825	$0.90M	0.0%	-2.7%	0.112%
11/9/2023	Deutsche Bank AG	16,224	$0.30M	0.0%	+15.3%	0.037%
11/9/2023	Citigroup Inc.	49,244	$0.90M	0.0%	+3.4%	0.113%
11/9/2023	UBS Group AG	38,003	$0.70M	0.0%	+1,998.5%	0.087%
11/8/2023	Charles Schwab Investment Management Inc.	212,104	$3.89M	0.0%	-13.8%	0.486%
11/8/2023	Swiss National Bank	57,600	$1.06M	0.0%	+2.1%	0.132%
11/7/2023	Barclays PLC	63,177	$1.15M	0.0%	-7.8%	0.145%
11/7/2023	Fox Run Management L.L.C.	12,621	$0.23M	0.1%	N/A	0.029%
10/27/2023	Hennion & Walsh Asset Management Inc.	27,731	$0.51M	0.0%	+89.5%	0.064%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	19,163	$0.35M	0.0%	-3.8%	0.044%
10/24/2023	Bank of New York Mellon Corp	114,388	$2.10M	0.0%	-0.8%	0.262%
8/24/2023	Perceptive Advisors LLC	3,624,182	$94.08M	2.7%	+0.2%	8.299%
8/21/2023	California State Teachers Retirement System	34,437	$0.89M	0.0%	-1.8%	0.079%
8/16/2023	Nuveen Asset Management LLC	89,537	$2.32M	0.0%	+1.0%	0.205%
8/15/2023	Alliancebernstein L.P.	45,437	$1.18M	0.0%	+29.1%	0.104%
8/15/2023	Wells Fargo & Company MN	46,865	$1.22M	0.0%	+9.7%	0.107%
8/15/2023	Walleye Capital LLC	33,106	$0.86M	0.0%	-78.3%	0.076%
8/15/2023	Woodline Partners LP	1,524,915	$39.59M	0.5%	+385.3%	3.492%
8/15/2023	Goldman Sachs Group Inc.	250,417	$6.50M	0.0%	+42.9%	0.573%
8/15/2023	Point72 Asset Management L.P.	319,500	$8.29M	0.0%	+33.6%	0.732%
8/15/2023	Royal Bank of Canada	3,360	$87K	0.0%	+51.0%	0.008%
8/15/2023	Sphera Funds Management LTD.	50,000	$1.30M	0.2%	N/A	0.114%
8/14/2023	Tower Research Capital LLC TRC	2,435	$63K	0.0%	-61.6%	0.006%
8/14/2023	ArrowMark Colorado Holdings LLC	958,880	$24.89M	0.3%	+1.9%	2.196%
8/14/2023	Marshall Wace LLP	11,693	$0.30M	0.0%	N/A	0.027%
8/14/2023	State Street Corp	1,817,416	$47.18M	0.0%	-12.5%	4.162%
8/14/2023	Bellevue Group AG	48,800	$1.27M	0.0%	+64.3%	0.112%
8/14/2023	Nuveen Asset Management LLC	89,537	$2.32M	0.0%	+1.0%	0.205%
8/11/2023	Renaissance Technologies LLC	92,300	$2.40M	0.0%	-56.8%	0.211%
8/11/2023	Natixis	45,000	$1.17M	0.0%	N/A	0.103%
8/11/2023	Credit Suisse AG	29,403	$0.76M	0.0%	+44.2%	0.067%
8/11/2023	BlackRock Inc.	2,546,603	$66.11M	0.0%	+9.2%	5.831%
8/11/2023	Velan Capital Investment Management LP	25,000	$0.65M	0.6%	N/A	0.057%
8/11/2023	State Board of Administration of Florida Retirement System	9,748	$0.25M	0.0%	N/A	0.022%

Data available starting January 2016

Inhibrx, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, colorectal cancer, ewing sarcoma, and pancreatic adenocarcinoma; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also develops INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company has license and collaboration agreements with 2seventy bio, Inc. and Bristol-Myers Squibb Company. Inhibrx, Inc. was incorporated in 2009 and is headquartered in La Jolla, California.

Today's Range

Now: $34.45

$34.45

$34.83

50 Day Range

MA: $35.98

$34.61

$39.56

52 Week Range

Now: $34.45

$14.31

$39.79

Volume

415,786 shs

Average Volume

698,410 shs

Market Capitalization

$1.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.91

Who are the company insiders with the largest holdings of Inhibrx?: Inhibrx's top insider shareholders include:
Jon Faiz Kayyem (Director)
Mark Lappe (CEO)
Brendan P Eckelman (Insider)
Global Investors Lp Viking (Major Shareholder)
Learn More about top insider investors at Inhibrx.
Who are the major institutional investors of Inhibrx?: Inhibrx's top institutional shareholders include:
Hennion & Walsh Asset Management Inc. — 0.06%
Learn More about top institutional investors of Inhibrx stock.
Which major investors are buying Inhibrx stock?: In the last quarter, INBX stock was purchased by institutional investors including:
Hennion & Walsh Asset Management Inc.

The Next Nvidia?

From InvestorPlace | Ad

Go here now for this breaking story.